Tildrakizumab-asmn Injection (Ilumya)

    loading  Checking for direct PDF access through Ovid

Abstract

Tildrakizumab-asmn is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Related Topics

    loading  Loading Related Articles